Are you Dr. Patnaik?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 67 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 507-255-3125- Is this information wrong?
Summary
- Dr. Mrinal Patnaik, MD is an oncologist in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with Mayo Clinic Hospital - Rochester.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2008 - 2011
- University of MinnesotaResidency, Internal Medicine, 2005 - 2008
- Grant Medical CollegeClass of 2000
Certifications & Licensure
- MN State Medical License 2007 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
- Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Start of enrollment: 2013 Dec 24
- A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Start of enrollment: 2015 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.Lih En Hong, Mihir D Wechalekar, Monika Kutyna, Annabelle Small, Kelly Lim, Chloe Thompson-Peach, Joule J Li, Rakchha Chhetri, Hamish S Scott, Anna Brown, Christopher ...> ;Blood. 2024 May 2
- Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, Denise A Whalen, Kayla J Kolbert, Kaitlin J Sikkink, Sarah A Kroc, Teresa Kruisselbrink, Gabriell...> ;Journal of Translational Medicine. 2024 Apr 30
- The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance.Marissa M Li, Anmol Baranwal, Mark Gurney, Syed Naseem Shah, Aref Al-Kali, Hassan B Alkhateeb, James M Foran, Cecilia Arana-Yi, Laura Ongie, Dong Chen, Abhishek A Mang...> ;Blood Advances. 2024 Apr 2
- Join now to see all
Press Mentions
- Mayo Clinic Physician Cracks Patient’s Mysterious Illness with Epigenetics TechnologyMarch 10th, 2021
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota